This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: John Mark Francis Gardner: Innovator in Pharmaceutical Compounds
Introduction
John Mark Francis Gardner is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of parasitic diseases. With a total of 2 patents, Gardner's work focuses on innovative compounds that address critical health issues.
Latest Patents
Gardner's latest patents include groundbreaking inventions aimed at treating fascioliasis and schistosomiasis. The first patent involves compounds and pharmaceutically acceptable salts or solvates for the treatment or prevention of fascioliasis. These compounds are not only novel but also serve as inhibitors of growth. The invention encompasses pharmaceutical compositions that include these compounds, which are particularly useful as medicaments for treating schistosomiasis, also known as bilharzia.
The second patent features substituted imidazo[1,2-a]pyrazines, pyrazolo[1,5-c]pyrimidines, pyrazolo[1,5-a]pyridines, and purines. These compounds, represented by specific formulas, also act as inhibitors of growth. Similar to the first patent, this invention relates to pharmaceutical compositions that utilize these compounds as medicaments for the treatment or prevention of schistosomiasis.
Career Highlights
Gardner is associated with Merck Patent GmbH, where he has been instrumental in developing innovative pharmaceutical solutions. His work has contributed to advancing medical treatments and improving patient outcomes in the field of parasitology.
Collaborations
Gardner collaborates with Andrew Simon Bell, enhancing the research and development efforts within their projects. Their partnership has fostered innovation and the exploration of new therapeutic avenues.
Conclusion
John Mark Francis Gardner's contributions to pharmaceutical inventions demonstrate his commitment to addressing significant health challenges. His innovative patents reflect a dedication to improving treatments for parasitic diseases, showcasing the impact of his work in the medical field.